Elevated AREG expression has been observed in multiple cancer types, including breast, lung, and colorectal cancers, and promotes tumor progression, including cell proliferation, survival, and metastatic potential, by activating EGFR and its downstream signaling pathways such as MAPK, STAT3, and PI3K/AKT [14,15]. Here, AREG is linked to neoplasm.